Compared with level 1 and 2 interventions, level 3 interventions are less feasible and may
not always be justifiable—in the short-term—for all people in developing countries, given …

The global prevalence of diabetes currently exceeds 400 million and is projected to increase
to more than 600 million affected persons by the year 2035. Developing countries will …

In his report in the October 2017 issue of MEDICC Review, Vega-Jiménez stressed that the
design and integration of a prediabetes (intermediate hyperglycemia) registry would serve …

OBJECTIVE—In the Indian Diabetes Prevention Programme (IDPP), a 3-year randomized,
controlled trial, lifestyle modification (LSM) and metformin helped to prevent type 2 diabetes …

AIM: To identify the newest approaches to type 2 diabetes (T2DM) prevention and control in
the developing world context. METHODS: We conducted a systematic review of published …

Although diabetes is now a worldwide epidemic, the rate of increase in its prevalence in
developing countries is alarming. By the year 2025, more than three-quarters of all persons …

OBJECTIVE To synthesize the cost-effectiveness (CE) of interventions to prevent and control
diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS We …

OBJECTIVE Effective interventions to prevent, delay, or remit diabetes are currently
available. However, their impact on the prevalence of diabetes at the population level is …

The epidemiological and economic burden of diabetes poses one of the main challenges for
health systems worldwide. This is particularly relevant in middle-income countries because …

OBJECTIVE: To examine the effectiveness of the health system response to the challenge of
diabetes across different settings and explore the inequalities in diabetes care that are …